JLJennie Louise

Jennie Louise

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jennie Louise has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    What Is the Contribution of Maternal BMI to the Risk of Adverse Pregnancy Outcomes?

    by Megan Mitchell, Andrea R. Deussen, Amanda J. Poprzeczny, Laura J. Slade, Jennie Louise, Jodie M. Dodd

    Background: The associations between increased maternal body mass index (BMI) in pregnancy and adverse pregnancy outcomes for women and their infants are well known. Describing and understanding risk accurately can be problematic for women and clinicians, with a true picture often obscured by common reporting practices such as categorisation of BMI and use of only relative measures of risk. Aims: The aims were to investigate relationships between maternal BMI, parity, and adverse pregnancy outcomes; provide estimates of both relative and absolute risks of adverse pregnancy outcomes; and consider the potential contribution from unmeasured confounding. Materials and Methods: Data from the South Australian Perinatal Outcomes unit from 2013 to 2017 inclusive were analysed for associations between BMI categories, BMI as a continuous variable, parity, and adverse pregnancy outcomes. Results: Data from 65,285 women were included. A 5 kg/m 2 increase in maternal BMI was associated with an increased adjusted relative risk (aRR) of gestational diabetes between 1.3 and 1.4 times, though the adjusted risk difference (aRD) was just 3%, irrespective of parity. The aRR of pre‐eclampsia was 1.13 times and 1.43 times in nulliparous and multiparous women respectively; however, the aRD was less than 0.1% for all women. The absolute risk of pre‐eclampsia at a BMI of 20 was 0.7% for nulliparous and 0.2% for parous women, which increased to a risk of 0.9% for nulliparous and 0.4% for parous women. Conclusions: While risks of most adverse outcomes increase with increased BMI, we cannot rule out the possibility that a substantial amount of the observed effects are due to unmeasured confounding. Use of BMI categories leads to underestimation of the true risk for some women and overestimation for others. Use of only relative measures of risk may create an impression that the risks associated with BMI are more dramatic than the absolute risks would suggest. Additionally, parity substantially modifies the risks of BMI for many outcomes; for example, a woman with parity 1 and a BMI of 30 has about the same risk of pregnancy induced hypertension, and a lower risk of pre‐eclampsia, compared to a nulliparous woman of BMI 20. A more nuanced understanding of the risks of BMI is needed.

  • Real-world outcomes after initiation of Elexacaftor/tezacaftor/ivacaftor in an adolescent cohort with cystic fibrosis

    by James R Johnston, Martin Donnelley, Ronan Smith, Jennie Louise, Jodi Grunert, Carol La Vanda, Andrew Tai


  • Open Access

    Validation of the paediatric appendicitis risk calculator (pARC) in an Australian emergency department setting

    by Alexander Howes, Sanjeev Khurana, Jennie Louise, Isabella Watts, Rebecca Linke, Amit Kochar


  • Open Access

    Investigating discrepancies in findings between rigorous randomized trials and meta‐analyses evaluating pregnancy interventions to limit gestational weight gain

    by Jodie M. Dodd, Andrea R. Deussen, Amanda J. Poprzeczny, Laura J. Slade, Megan Mitchell, Jennie Louise

    Summary: Introduction: Robust randomized trials consistently demonstrate little impact from diet and physical activity interventions on gestational weight gain (GWG) and clinical outcomes, although meta‐analyses report some benefit. Our aim was to evaluate the effect of trial quality on treatment effect estimates and review conclusions. Methods: We conducted a systematic review of dietary and/or physical activity interventions for pregnant women with a body mass index ≥18.5 kg/m 2 . We assessed studies for risk of bias and methodological features impacting reliability. Outcomes included GWG; gestational diabetes mellitus (GDM); pre‐eclampsia; caesarean birth; and birth weight measures. For each outcome, a sequence of meta‐analyses was performed based on intervention group and level of potential bias in the effect estimate. Results: We identified 128 eligible studies. The most robust estimate from a combined diet and physical activity behavioral intervention, with only studies at negligible risk of bias, was a difference in GWG of 1.10 kg (95% CI −1.62 to −0.58; 17,755 women). There was no evidence of an effect on any clinical outcomes. Conclusions: Our findings highlight discrepancies produced by the indiscriminate inclusion of studies with methodological flaws in previous systematic reviews. Regular weighing of pregnant women is futile in the absence of clinical benefit.


  • Open Access

    Data processing choices can affect findings in differential methylation analyses: an investigation using data from the LIMIT RCT

    by Jennie Louise, Andrea R. Deussen, Jodie M. Dodd

    Objective A wide array of methods exist for processing and analysing DNA methylation data. We aimed to perform a systematic comparison of the behaviour of these methods, using cord blood DNAm from the LIMIT RCT, in relation to detecting hypothesised effects of interest (intervention and pre-pregnancy maternal BMI) as well as effects known to be spurious, and known to be present. Methods DNAm data, from 645 cord blood samples analysed using Illumina 450K BeadChip arrays, were normalised using three different methods (with probe filtering undertaken pre- or post- normalisation). Batch effects were handled with a supervised algorithm, an unsupervised algorithm, or adjustment in the analysis model. Analysis was undertaken with and without adjustment for estimated cell type proportions. The effects estimated included intervention and BMI (effects of interest in the original study), infant sex and randomly assigned groups. Data processing and analysis methods were compared in relation to number and identity of differentially methylated probes, rankings of probes by p value and log-fold-change, and distributions of p values and log-fold-change estimates. Results There were differences corresponding to each of the processing and analysis choices. Importantly, some combinations of data processing choices resulted in a substantial number of spurious ‘significant’ findings. We recommend greater emphasis on replication and greater use of sensitivity analyses.


  • Maternal and neonatal outcomes following the introduction of the Fetal Pillow at a tertiary maternity hospital: A retrospective cohort study

    by Kathrina Y.L. Chooi, Andrea R. Deussen, Jennie Louise, Sarah Cash, Jodie M. Dodd

    Background: Caesarean birth at full cervical dilatation can be technically challenging and may be associated with increased risks of maternal and neonatal morbidity, often secondary to difficulties in delivering a deeply impacted fetal head. The Fetal Pillow is a device designed to elevate an impacted fetal head out of the pelvis and reduce birth trauma.Aims: To evaluate birth outcomes following the introduction of the Fetal Pillow at a tertiary maternity hospital.Materials and Methods: This retrospective cohort study included all caesarean births at full cervical dilatation where the Fetal Pillow was utilised and compared with caesarean births where the Fetal Pillow was not used from October 2018 to December 2019. Maternal outcomes included uterine incision extension, blood loss, high dependency unit admission and postoperative length of stay. Neonatal outcomes included Apgar scores, resuscitation, cord arterial blood pH and lactate, nursery admission, birth trauma, jaundice and seizures.Results: There were 53 caesarean births where the Fetal Pillow was utilised and 48 where it was not. Baseline characteristics were similar between groups with mean maternal age across both groups of 30.4 (±5.3) years, mean gestational age at birth of 39.5 (±1.2) weeks and mean infant birth weight of 3543 (±441) g. There were no statistically significant differences between the two study groups for the maternal and neonatal outcomes considered.Conclusions: There was no evidence that use of the Fetal Pillow to elevate an impacted fetal head during caesarean birth when cervical dilatation is >7 cm was associated with a reduced rate of adverse maternal and neonatal outcomes.


  • Open Access

    Childhood follow‐up of the GRoW randomized trial: Metformin in addition to dietary and lifestyle advice for pregnant women with overweight or obesity

    by Andrea R. Deussen, Jennie Louise, Jodie M. Dodd

    Summary: Background: Metformin for women with overweight or obesity during pregnancy has been evaluated in randomized trials to reduce adverse pregnancy and birth outcomes. The effect on longer‐term child health remains of interest.Objectives: To evaluate the effect of in‐utero exposure to metformin on child health compared with no exposure.Methods: We assessed children born to 513 women who participated in the Metformin in addition to dietary and lifestyle advice for pregnant women with overweight or obesity: the GRoW randomized trial, where women were randomized to receive either metformin or placebo during pregnancy. Child weight, height, anthropometry, diet, physical activity and neurodevelopment were assessed at six and 18 months and three to five years of age. The main outcome was BMI z‐score > 85th centile for age and sex.Results: The number of children with BMI >85th centile was similar between treatment groups at all time points. At 18 months and three to five years of age, more than half of the children had a BMI z‐score > 85th centile, indicating a high risk of childhood obesity.Conclusions: We did not show evidence of the benefit of metformin for children of women with overweight or obesity during pregnancy adding to the growing literature on the lack of effect of pregnancy interventions in reducing longer‐term risks of childhood obesity.


  • Open Access

    Effect of an antenatal diet and lifestyle intervention and maternal BMI on cord blood DNA methylation in infants of overweight and obese women: The LIMIT Randomised Controlled Trial

    by Jennie Louise, Andrea R. Deussen, Berthold Koletzko, Julie Owens, Richard Saffery, Jodie M. Dodd

    Background: To investigate the effect of an antenatal diet and lifestyle intervention, and maternal pre-pregnancy overweight or obesity, on infant cord blood DNA methylation. Methods: We measured DNA methylation in 645 cord blood samples from participants in the LIMIT study (an antenatal diet and lifestyle intervention for women with early pregnancy BMI ≥25.0 kg/m2) using the Illumina 450K BeadChip array, and tested for any differential methylation related to the intervention, and to maternal early pregnancy BMI. We also analysed differential methylation in relation to selected candidate genes. Results: No CpG sites were significantly differentially methylated in relation to either the diet and lifestyle intervention, or with maternal early pregnancy BMI. There was no significant differential methylation in any of the selected genes related to the intervention, or to maternal BMI. Conclusion: We found no evidence of an effect of either antenatal diet and lifestyle, or of maternal early pregnancy BMI, on cord blood DNA methylation. Clinical trials registration: ACTRN12607000161426


  • Open Access

    Data Processing Choices Can Affect Findings in Differential Methylation Analyses: An Investigation Using Data from the LIMIT RCT

    by Jennie Louise, Andrea R Deussen, Jodie M Dodd

    Objective: A wide array of methods exist for processing and analysing DNA methylation data. We aimed to perform a systematic comparison of the behaviour of these methods, using cord blood DNAm from the LIMIT RCT, in relation to detecting hypothesised effects of interest (intervention and pre-pregnancy maternal BMI) as well as effects known to be spurious, and known to be present. Methods: DNAm data, from 645 cord blood samples analysed using Illumina 450K BeadChip arrays, were normalised using three different methods (with probe filtering undertaken pre- or post-normalisation). Batch effects were handled with a supervised algorithm, an unsupervised algorithm, or adjustment in the analysis model. Analysis was undertaken with and without adjustment for estimated cell type proportions. The effects estimated included intervention and BMI (effects of interest in the original study), infant sex and randomly assigned groups. Data processing and analysis methods were compared in relation to number and identity of differentially methylated probes, rankings of probes by p value and log-fold-change, and distributions of p values and log-fold-change estimates. Results: There were differences corresponding to each of the processing and analysis choices. Importantly, some combinations of data processing choices resulted in a substantial number of spurious ‘significant’ findings. We recommend greater emphasis on replication and greater use of sensitivity analyses. Clinical Trials Registration: ACTRN12607000161426

  • Open Access

    Gestational Weight Gain—Re-Examining the Current Paradigm

    by Jennie Louise, Andrea R. Deussen, Jodie M. Dodd

    Our aim was to investigate the underlying assumptions of the current gestational weight gain (GWG) paradigm, specifically that—(1) GWG is modifiable through diet and physical activity; (2) optimal GWG and risk of excess GWG, vary by pre-pregnancy body mass index (BMI) category and (3) the association between GWG and adverse pregnancy outcomes is causal. Using data from three large, harmonized randomized controlled trials (RCTs) of interventions to limit GWG and improve pregnancy outcomes and with appropriate regression models, we investigated the link between diet and physical activity and GWG; the relationships between pre-pregnancy BMI, GWG and birth weight z-score; and the evidence for a causal relationship between GWG and pregnancy outcomes. We found little evidence that diet and physical activity in pregnancy affected GWG and that the observed relationships between GWG and adverse pregnancy outcomes are causal in nature. Further, while there is evidence that optimal GWG may be lower for women with higher BMI, target ranges defined by BMI categories do not accurately reflect risk of adverse outcomes. Our findings cast doubt upon current advice regarding GWG, particularly for overweight and obese women and suggest that a change in focus is warranted.